Catalyst Wire Dossier Catalyst Wire Dossier

NORGESIC

Orphenadrine citrate, aspirin and caffeine · Galt Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NORGESIC, covering 2021-04-28 to 2024-11-21. Get the full timeline:

Most recent: FDA Approved: NORGESIC — Supplemental Application (Galt Pharmaceuticals, LLC)

See pricing